Imara Announces Stockholder Approval of Merger With Enliven
February 22, 2023 16:01 ET | Imara, Inc.
-- Combined Company to Trade on Nasdaq Under Ticker “ELVN” ---- Imara Announces 1-for-4 Reverse Stock Split of Common Stock -- BROOKLINE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Imara Inc....
Enliven Therapeutics and Imara Announce Merger Agreement
October 13, 2022 16:35 ET | Imara, Inc.
Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Enliven’s portfolio of precision oncology programsCombined company is expected to have a cash balance of...